SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016882
Filing Date
2022-08-11
Accepted
2022-08-11 16:15:57
Documents
89
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fdmt-20220630.htm   iXBRL 10-Q 3507180
2 EX-31.1 fdmt-ex31_1.htm EX-31.1 21611
3 EX-31.2 fdmt-ex31_2.htm EX-31.2 21520
4 EX-32.1 fdmt-ex32_1.htm EX-32.1 15716
  Complete submission text file 0000950170-22-016882.txt   12348099

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fdmt-20220630_pre.xml EX-101.PRE 411267
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fdmt-20220630_def.xml EX-101.DEF 243338
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fdmt-20220630.xsd EX-101.SCH 75844
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fdmt-20220630_cal.xml EX-101.CAL 43711
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fdmt-20220630_lab.xml EX-101.LAB 530692
83 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20220630_htm.xml XML 2569375
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39782 | Film No.: 221156073
SIC: 2836 Biological Products, (No Diagnostic Substances)